LeonaBio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
LeonaBio, Inc. (LONA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-14
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $0.00.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $0.00.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $0.00.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $200.00K, a 0.00% change from fiscal 2023.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $200.00K, a 93.33% decline from fiscal 2022.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $3.00M, a 3.23% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-03-31 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-06 | $200.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $200.00K derived: sum of 3 quarters · filed 2026-08-14 | $200.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $200.00K derived: sum of 2 quarters · filed 2026-05-07 | $200.00K derived: sum of 3 quarters · filed 2026-05-07 | $200.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $200.00K derived: sum of 2 quarters · filed 2026-03-31 | $200.00K derived: sum of 3 quarters · filed 2026-03-31 | $200.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $200.00K 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-05-09 | $0.00 derived: sum of 3 quarters · filed 2025-05-09 | $0.00 derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $200.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $200.00K 10-Q · filed 2024-11-07 | $200.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $200.00K 10-Q · filed 2024-08-01 | $200.00K derived: sum of 3 quarters · filed 2024-08-01 | $200.00K derived: sum of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-15 | $200.00K derived: sum of 2 quarters · filed 2024-05-15 | $200.00K derived: sum of 3 quarters · filed 2024-05-15 | $500.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $300.00K derived: sum of 3 quarters · filed 2024-02-22 | $3.00M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $300.00K derived: sum of 2 quarters · filed 2023-11-09 | $3.00M 10-Q · filed 2023-11-09 | $4.10M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $3.00M 10-Q · filed 2023-08-10 | $4.10M derived: sum of 3 quarters · filed 2023-08-10 | $4.80M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $2.70M 10-Q · filed 2023-05-11 | $3.80M derived: sum of 2 quarters · filed 2023-05-11 | $4.50M derived: sum of 3 quarters · filed 2023-05-11 | $4.70M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.80M derived: sum of 2 quarters · filed 2023-03-23 | $2.00M derived: sum of 3 quarters · filed 2023-03-23 | $3.10M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $900.00K derived: sum of 2 quarters · filed 2022-11-10 | $2.00M 10-Q · filed 2022-11-10 | $10.60M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.30M 10-Q · filed 2022-08-15 | $9.90M derived: sum of 3 quarters · filed 2022-08-15 | $18.00M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $1.10M 10-Q · filed 2022-05-12 | $9.70M derived: sum of 2 quarters · filed 2022-05-12 | $17.80M derived: sum of 3 quarters · filed 2022-05-12 | $19.10M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $16.70M derived: sum of 2 quarters · filed 2022-03-28 | $18.00M derived: sum of 3 quarters · filed 2022-03-28 | $18.00M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $9.40M derived: sum of 2 quarters · filed 2021-11-10 | $9.40M 10-Q · filed 2021-11-10 | $9.44M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $1.30M 10-Q · filed 2021-08-16 | $1.33M derived: sum of 3 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $0.10 10-Q · filed 2021-05-13 | $35.00K derived: sum of 2 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $39.00K 10-K · filed 2021-03-25 | |||
| 2019-09-30 | $4.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |